class I sel. histone deacetylase (HDAC) inhib.

in vitro HIV reactivation for HIV eradication

from structure-based design of prior ligand

ACS Med. Chem. Lett., Jun. 22, 2020

Merck & Co., Kenilworth, NJ / West Point

Structure of compound 10

“Compound 10” is a potent and selective inhibitor of Class I histone deacetylases (HDAC1/2/3) which increases HIV activity in treatment-suppressed patient immune cells for the goal of eradicating HIV from…


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: